ID: ALA394956

Max Phase: Preclinical

Molecular Formula: C37H43N5O

Molecular Weight: 573.78

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): KYS-05090
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccc(-c2ccccc2)cc1

    Standard InChI:  InChI=1S/C37H43N5O/c1-40(2)25-13-6-14-26-41(3)37-39-34-20-12-11-19-33(34)35(27-36(43)38-28-29-15-7-4-8-16-29)42(37)32-23-21-31(22-24-32)30-17-9-5-10-18-30/h4-5,7-12,15-24,35H,6,13-14,25-28H2,1-3H3,(H,38,43)

    Standard InChI Key:  QVXCZTNUVKNCGU-UHFFFAOYSA-N

    Associated Targets(Human)

    Voltage-gated T-type calcium channel alpha-1G subunit 1361 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Voltage-gated N-type calcium channel alpha-1B subunit 743 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    A549 127892 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    DU-145 51482 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HT-29 80576 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SK-MEL-2 46422 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SK-OV-3 52876 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HeLa 62764 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    LNCaP 8286 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    MDA-MB-231 73002 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SK-BR-3 5175 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    A2780 11979 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Voltage-gated T-type calcium channel alpha-1I subunit 425 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Voltage-gated T-type calcium channel alpha-1H subunit 1913 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HCT-116 91556 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Mus musculus 284745 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 573.78Molecular Weight (Monoisotopic): 573.3468AlogP: 7.27#Rotatable Bonds: 12
    Polar Surface Area: 51.18Molecular Species: BASEHBA: 5HBD: 1
    #RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
    CX Acidic pKa: CX Basic pKa: 9.81CX LogP: 6.70CX LogD: 3.46
    Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: -0.68

    References

    1. Seo HN, Choi JY, Choe YJ, Kim Y, Rhim H, Lee SH, Kim J, Joo DJ, Lee JY..  (2007)  Discovery of potent T-type calcium channel blocker.,  17  (21): [PMID:17869104] [10.1016/j.bmcl.2007.08.070]
    2. Heo JH, Seo HN, Choe YJ, Kim S, Oh CR, Kim YD, Rhim H, Choo DJ, Kim J, Lee JY..  (2008)  T-type Ca2+ channel blockers suppress the growth of human cancer cells.,  18  (14): [PMID:18585035] [10.1016/j.bmcl.2008.06.034]
    3. Jeong JA, Cho H, Jung SY, Kang HB, Park JY, Kim J, Choo DJ, Lee JY..  (2010)  3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).,  20  (1): [PMID:19951839] [10.1016/j.bmcl.2009.11.049]
    4. Jung SY, Lee SH, Kang HB, Park HA, Chang SK, Kim J, Choo DJ, Oh CR, Kim YD, Seo JH, Lee KT, Lee JY..  (2010)  Antitumor activity of 3,4-dihydroquinazoline dihydrochloride in A549 xenograft nude mice.,  20  (22): [PMID:20884207] [10.1016/j.bmcl.2010.09.020]
    5. Jang SJ, Choi HW, Choi DL, Cho S, Rim HK, Choi HE, Kim KS, Huang M, Rhim H, Lee KT, Lee JY..  (2013)  In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.,  23  (24): [PMID:24220170] [10.1016/j.bmcl.2013.10.049]
    6. Nam Y, Ryu KD, Jang C, Moon YH, Kim M, Ko D, Chung KS, Gandini MA, Lee KT, Zamponi GW, Lee JY..  (2020)  Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.,  28  (11): [PMID:32327350] [10.1016/j.bmc.2020.115491]

    Source